Dr. Messinger was recognized for his devotion to the Registry’s mission of improving the outcomes for children and adults with PPB and other DICER1-related cancers.
Dr. Stuart Winter, chief research officer, is one of 52 authors on a paper that will soon be published in “Nature,” the world’s leading multidisciplinary science journal. The study is titled “The Genomic Basis of T-Lineage Acute Lymphoblastic Leukemia (T-ALL).” Congratulations Dr. Winter and team on these remarkable advances!
Meet Dario Chavez. Shortly after graduating high school, Dario found out he had a grapefruit-sized tumor in his abdomen. Tests revealed the 19-year-old had rhabdomyosarcoma, a rare type of cancer. Children's Minnesota became his home away from home during his treatment. Because of the chemotherapy and treatment to cure his cancer, it was expected that Dario would not be able to have kids in the future. But today, Dario is not only married to his high school sweetheart, but the proud father of two boys. Learn more about his story and watch as Dario reunites with his physician, Dr. Susan Sencer, vice president and chief of specialty pediatric, nearly 20 years after his diagnosis.
Oct. 14 holds a special place in the hearts of Marcy Anderson and her daughter Ashley. It’s a reminder of their resilience through uncertain times as it was on that date in 1986, that Ashley had her final chemotherapy treatment at Children’s Minnesota in St. Paul.
When 18-year-old Jordan “Jordy” Hansen talks about the big moments in his young life – hockey is usually involved. But one of the hockey memories that sticks isn’t about scoring a game-winning goal. It was at a tournament in 2017 and his mom noticed what turned out to be a symptom of a brain tumor.
Cutting edge findings from the Children’s Minnesota Cancer and Blood Disorders research team and collaborators show variants in the deep intronic (noncoding) region of DICER1 may increase risk for tumor development in kids and young adults.
Children’s Minnesota is pleased to announce that Katie Greenwood, MD, FAAP; Jennifer Hess, DO, MS, MPH; Megan Hilgers, MD; and Chelsea Self, MD, have joined the expanding cancer and blood disorders program.
A new antibody-drug conjugate (ADC) that targets B-cell acute lymphoblastic leukemia (B-ALL) is showing early promise in the fight against childhood leukemia. ALL is a cancer that involves the white blood cells of the bone marrow. It is the most common leukemia diagnosed in children and young adults.
During the event, children battling cancer participated in Hyundai Hope On Wheels’ signature Handprint Ceremony, in which they dipped their hands in paint and placed their handprints on a white 2023 Hyundai Tucson.
Some of our kid experts for the cancer and blood disorders program have joined Team Superstars and will be raising funds for the Cancer Kids Fund while running the Medtronic Twin Cities 10 Mile race on Sunday, Oct. 1, 2023.